Tech Company Financing Transactions

Flexion Therapeutics Funding Round

On 12/4/2012, Flexion Therapeutics secured $20 million in Series B financing from Novo Ventures, 5AM Ventures and Pfizer Venture Investments.

Transaction Overview

Company Name
Flexion Therapeutics
Announced On
12/4/2012
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors

Novo Ventures (Lead Investor) (Heath Lukatch)

5AM Ventures (Andrew Schwab)

Pfizer Venture Investments (Elaine Jones)

Sofinnova Ventures (Rafaele Tordjman)

Versant Ventures (Brad Bolzon)

Proceeds Purpose
Proceeds will be used to fund late stage clinical development of the company's portfolio of intra-articular, sustained release therapies for the treatment of osteoarthritis.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10 Mall Rd. 301
Burlington, MA 01803
USA
Phone
(781) 305-7777
Website
www.flexiontherapeutics.com
Email Address
[email protected]
Overview
Flexion Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies.
Profile
Flexion Therapeutics LinkedIn Company Profile
Social Media
Flexion Therapeutics Company Twitter Account
Company News
Flexion Therapeutics News
Facebook
Flexion Therapeutics on Facebook
YouTube
Flexion Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Clayman
  Michael Clayman LinkedIn Profile  Michael Clayman Twitter Account  Michael Clayman News  Michael Clayman on Facebook
Chief Medical Officer
Scott Kelley
  Scott Kelley LinkedIn Profile  Scott Kelley Twitter Account  Scott Kelley News  Scott Kelley on Facebook
Vice President
Christina Willwerth
  Christina Willwerth LinkedIn Profile  Christina Willwerth Twitter Account  Christina Willwerth News  Christina Willwerth on Facebook
VP - Bus. Development
Adam Muzikant
  Adam Muzikant LinkedIn Profile  Adam Muzikant Twitter Account  Adam Muzikant News  Adam Muzikant on Facebook
VP - General Counsel
Mark Levine
  Mark Levine LinkedIn Profile  Mark Levine Twitter Account  Mark Levine News  Mark Levine on Facebook
VP - Operations
Daniel Leblanc
  Daniel Leblanc LinkedIn Profile  Daniel Leblanc Twitter Account  Daniel Leblanc News  Daniel Leblanc on Facebook
VP - Regulatory Affairs
Kerry Wentworth
  Kerry Wentworth LinkedIn Profile  Kerry Wentworth Twitter Account  Kerry Wentworth News  Kerry Wentworth on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/3/2012: SmartSheet venture capital transaction
Next: 12/4/2012: HydroNovation venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC transactions reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.